Health minister Greg Hunt says the government will work with the sector to "ensure" Australian patients access gene and cell therapies as Alnylam Pharmaceuticals, the company with the first approved RNA interference therapeutic, confirms it has no current plan to bring ONPATTRO to Australia. …
Greg Hunt: Will work to 'ensure' patient access to gene and cell therapies
June 21, 2019 Latest NewsNews of the Day
Latest Video
New Stories
-
New report highlights growing gene and cell therapy industry
January 24, 2020 - - Latest News -
Australian access behind comparable countries?
January 24, 2020 - - Latest News -
CSL Behring welcomes new presentations for genetic condition
January 24, 2020 - - Latest News -
Couple call on Jacinda Ardern to act on PHARMAC
January 24, 2020 - - Latest News -
Transparency of process is more important than transparency of outcome
January 23, 2020 - - Latest News -
CSL makes US-list of Best Employers for Diversity
January 23, 2020 - - Latest News -
AbbVie welcomes RINVOQ approval
January 23, 2020 - - Latest News